Skip to main content

Table 1 Percentage variation after target addition for the tested condition

From: BioCode gold-nanobeacon for the detection of fusion transcripts causing chronic myeloid leukemia

 

Reaction blank (%)

ABL (%)

BCR (%)

Negative (%)

Positive (%)

Donor

 BioCode-e13

0.5

5.7

33.6

4.0

39.8

 BioCode-e14

8.9

18.2

26.3

1.6

135.6

Acceptors

 BioCode-e13

−8.4

1

10.3

−2.8

53.2

 BioCode-e14

−2.6

0.8

1.1

4.5

50.9